Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros




Base de datos
Asunto de la revista
Intervalo de año de publicación
1.
Pituitary ; 27(2): 230-237, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38296897

RESUMEN

Granulomatosis with polyangiitis (GPA) rarely involves the pituitary gland. Pituitary involvement has been reported in ~ 1% of all cases of GPA. Most commonly, pituitary swelling and inflammation results in symptoms due to pituitary mass effect and arginine vasopressin deficiency. To date, there are no pituitary-specific treatment guidelines for this rare condition. We present three patients with GPA-related hypophysitis highlighting the spectrum of pituitary involvement. All three patients were successfully treated with immunosuppressive regimens that included rituximab (RTX). Following remission induction with high-dose glucocorticoids, patients received 6 monthly RTX for remission maintenance. RTX was well tolerated without significant side effects.


Asunto(s)
Granulomatosis con Poliangitis , Hipofisitis , Enfermedades de la Hipófisis , Humanos , Granulomatosis con Poliangitis/tratamiento farmacológico , Resultado del Tratamiento , Rituximab/uso terapéutico , Enfermedades de la Hipófisis/tratamiento farmacológico , Hipofisitis/tratamiento farmacológico , Hipófisis , Inducción de Remisión , Estudios Retrospectivos
2.
J Med Case Rep ; 9: 267, 2015 Nov 23.
Artículo en Inglés | MEDLINE | ID: mdl-26593089

RESUMEN

INTRODUCTION: Unexplained hyperammonemic coma in adults can be a medical dilemma in the absence of triggering factors and known comorbidities. Ornithine transcarbamylase deficiency presents most commonly with hyperammonemic coma. Although a rare disorder, ornithine transcarbamylase deficiency is the most common of the urea cycle disorders, which can occur both in children, and less commonly, in adults. The urea cycle disorder is usually acquired as an X-linked trait, and very rarely, similar to our reported case, may be acquired as a "new" mutation. Mutations that lead to later-onset presentations may lead to life-threatening disease and may be unrecognized, particularly when the first clinical symptoms occur in adulthood. CASE PRESENTATION: We report the case of a previously healthy 17-year-old white man who developed a prolonged seizure and a rapid decline in mental status leading to coma over a 3-day period. Analysis of the OTC gene showed a 119G variant, which was identified in exon 2 of the OTC gene by sequencing. CONCLUSIONS: A diagnosis of ornithine transcarbamylase deficiency should be considered in adult patients who present with unexplained hyperammonemic coma and for all adult patients presenting with cryptogenic new-onset seizure and laboratory finding of elevated blood ammonia levels. This reported case highlights the importance of early recognition of this potentially reversible cause of life-threatening encephalopathy, as timely recognition and appropriate treatment can be lifesaving.


Asunto(s)
Coma/etiología , Enterocolitis Seudomembranosa/complicaciones , Hiperamonemia/diagnóstico , Enfermedad por Deficiencia de Ornitina Carbamoiltransferasa/diagnóstico , Ornitina Carbamoiltransferasa/metabolismo , Neumonía Asociada al Ventilador/complicaciones , Convulsiones/etiología , Urea/metabolismo , Adolescente , Clostridioides difficile/patogenicidad , Enterocolitis Seudomembranosa/inmunología , Resultado Fatal , Humanos , Hiperamonemia/etiología , Hiperamonemia/genética , Masculino , Mutación , Enfermedad por Deficiencia de Ornitina Carbamoiltransferasa/complicaciones , Enfermedad por Deficiencia de Ornitina Carbamoiltransferasa/genética , Neumonía Asociada al Ventilador/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA